StonvexLoading…
StonvexStonvexStonvexCore line items from HLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.29B | $1.36B | $1.29B | $873.10M |
Operating Income | $65.14M | $127.44M | $63.51M | $-44.85M |
Net Income | $30.83M | $55.64M | $-10.84M | $-87.78M |
EPS (Diluted) | $0.21 | $0.36 | $-0.07 | $-0.58 |
Total Assets | $2.62B | $2.60B | $2.56B | $2.39B |
Total Liabilities | $1.04B | $1.08B | $1.06B | $872.63M |
Cash & Equivalents | $445.20M | $368.03M | $332.19M | $186.60M |
Free Cash Flow OCF − CapEx | $120.41M | $162.72M | $132.87M | $17.60M |
Shares Outstanding | 148.45M | 154.70M | 150.92M | 151.28M |